RXRX News and Press, Recursion Pharmaceuticals Inc.

2026-03-08 12:15:00 ET Artificial intelligence (AI) is all the rage on Wall Street these days, but not every AI stock is equally successful. Some of the bigger names in the field, like Nvidia , have seen their shares soar in recent years, while other, smaller ones, like Recursion Phar...

2026-03-06 12:35:54 ET Recursion Pharmaceuticals, Inc. (RXRX) TD Cowen 46th Annual Health Care Conference March 2, 2026 9:50 AM EST... Read the full article on Seeking Alpha For further details see: Recursion Pharmaceuticals, Inc. (RXRX) Presents at TD Cowen 46th Annual Heal...

2026-03-05 10:05:27 ET More on iShares Core S&P Small-Cap ETF, Vanguard Small-Cap Index Fund ETF Shares, etc. Read the full article on Seeking Alpha For further details see: Most and least shorted small-to-mid-cap stocks

MENLO PARK, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced the appointment of Christopher Gibson, Ph.D., to PacBio’s Board of Directors. Dr. Gibson is the co-founder and Chairman of ...

2026-03-03 09:35:51 ET More on Short interest: Hims & Hers short interest climbs amid legal risk related to weight loss pill... Michael Saylor’s Strategy tops U.S. short list, but high short interest may not signal...

2026-03-02 16:32:24 ET Read the full article on Seeking Alpha For further details see: Recursion: Nvidia Sells Out, Collaboration Still Alive, Data Ahead

2026-02-26 14:00:43 ET Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) , a Salt Lake City–based biotechnology company focused on AI-driven, industrial-scale drug discovery, reported short interest of approximately 165.55 million shares as of Jan. 30, 2026—representing about ...

2026-02-25 15:19:16 ET Investment Overview Recursion Pharmaceuticals, Inc. ( RXRX ), the self-styled "clinical-stage TechBio company with a mission to decode biology to radically improve lives" (Source: 2025 annual report/ 10-K filing ), reported its earnings earlier tod...

2026-02-25 12:59:00 ET Image source: The Motley Fool. Wednesday, Feb. 25, 2026 at 8 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-25 12:48:35 ET More on Recursion Pharmaceuticals Recursion Pharmaceuticals, Inc. (RXRX) Q4 2025 Earnings Call Transcript Recursion Pharmaceuticals, Inc. (RXRX) Presents at 28th Annual Needham Growth Conference Transcript Recursion Pharmaceuticals: Stock Unres...